If listed, eligible patients would pay approximately $25 per script (general) or $7.70 per script (concession card holders), based on the January 2026 co-payment rates
What's New: August 2026 Update TRIUMPH-2 confirmed (July 23, 2026): Obesity + type 2 diabetes trial, 1,152 patients up to 20.8% weight loss and up to 1.6 percentage points HbA1c reduction at 80 weeks TRIUMPH-3 confirmed (July 23, 2026): Obesity + established cardiovascular disease trial, 1,949 patients up to 22.6% weight loss at 80 weeks, plus significant improvements in triglycerides, blood pressure, and inflammatory markers All four core TRIUMPH registrational trials are now complete TRIUMPH-1, TRIUMPH-2, TRIUMPH-3, and TRIUMPH-4 have all reported positive topline results TRIUMPH-4 confirmed final: 28.7% weight loss at 68 weeks topline results announced December 2025 TRIUMPH-1 confirmed (May 21, 2026): 28.3% average weight loss at 80 weeks in 2,339 patients
How much does oral tirzepatide cost
This has the potential to improve blood sugar control and significantly reduce the symptoms or progression of metabolic diseases